![Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News](https://www.ctvnews.ca/polopoly_fs/1.5615061.1633625370!/httpImage/image.jpeg_gen/derivatives/landscape_1020/image.jpeg)
Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News
![Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire](https://mms.businesswire.com/media/20201005005212/en/826961/5/AermonyRespiClick_ENG.jpg)
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
![Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product | Investor's Business Daily Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product | Investor's Business Daily](https://www.investors.com/wp-content/uploads/2018/01/stock-Teva-03-company-640x360.jpg)
Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product | Investor's Business Daily
![Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA® Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®](http://photos.newswire.ca/images/20151215_C6454_PHOTO_EN_564829.jpg)
Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®
![Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease](https://mma.prnewswire.com/media/686979/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_Teva_Cyc.jpg?p=facebook)